Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL980469 | 0.85 | TSHR (0.32) | TSHR | |
| SCHEMBL27906526 | 0.80 | HDAC1 (0.46) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL9277707 | 0.76 | HCAR2 (0.32) | TSHR | |
| SCHEMBL982729 | 0.75 | LMNA (0.35) | SLC6A3TSHR | |
| SCHEMBL27280419 | 0.71 | CHRM1 (0.38) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL981827 | 0.70 | HCAR2 (0.31) | TSHR | |
| SCHEMBL16353963 | 0.70 | HCAR2 (0.31) | TSHR | |
| SCHEMBL27449093 | 0.68 | TSHR (0.41) | TSHR | |
| SCHEMBL7738388 | 0.68 | CTSK (0.36) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL10842812 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250349901-A1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM SECONDARY BATTERY | LG ENERGY SOLUTION LTD (KR) | 2025-11-13 | — | — | US | claimed |
| EP-3940845-B1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME | NINGDE AMPEREX TECHNOLOGY LTD (CN) | 2025-01-22 | — | — | EP | claimed |
| US-12125983-B2 | Electrolyte and electrochemical device including the same | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2024-10-22 | — | — | US | claimed |
| EP-3940845-A1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME | NingDe Amperex Technology Limited (CN) | 2022-01-19 | — | — | EP | claimed |
| EP-4148851-B1 | ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE | NINGDE AMPEREX TECHNOLOGY LTD (CN) | 2026-05-13 | — | — | EP | disclosed |
| US-20260094882-A1 | LITHIUM-ION BATTERY | ZHUHAI COSMX BATTERY CO., LTD. (CN) | 2026-04-02 | — | — | US | disclosed |
| US-12537184-B2 | Electrochemical device and electronic device | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2026-01-27 | — | — | US | disclosed |
| EP-4657604-A2 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME | Ningde Amperex Technology Limited (CN) | 2025-12-03 | — | — | EP | disclosed |
| EP-4404324-B1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME | NINGDE AMPEREX TECHNOLOGY LTD (CN) | 2025-11-19 | — | — | EP | disclosed |
| US-20250349901-A1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM SECONDARY BATTERY | LG ENERGY SOLUTION LTD (KR) | 2025-11-13 | — | — | US | disclosed |
| US-12407022-B2 | Electrolyte and electrochemical device | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2025-09-02 | — | — | US | disclosed |
| EP-3940843-B1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME | NINGDE AMPEREX TECHNOLOGY LTD (CN) | 2025-07-23 | — | — | EP | disclosed |
| US-9780409-B2 | Nonaqueous electrolytic solution and nonaqueous-electrolyte battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-10-03 | — | — | US | disclosed |
| EP-2830143-A1 | NONAQUEOUS ELECTROLYTE AND NONAQUEOUS ELECTROLYTE CELL | Mitsubishi Chemical Corporation (JP) | 2015-01-28 | — | — | EP | disclosed |
| US-20150024284-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-01-22 | — | — | US | disclosed |
| US-20150004481-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-01-01 | — | — | US | disclosed |
| US-20130337317-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION, AND BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-12-19 | — | — | US | disclosed |
| US-20130244122-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME | ONUKI MASAMICHI (JP) | 2013-09-19 | — | — | US | disclosed |
| US-20120219866-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-08-30 | — | — | US | disclosed |
| EP-2475041-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION, AND NON-AQUEOUS ELECTROLYTE BATTERY COMPRISING SAME | Mitsubishi Chemical Corporation (JP) | 2012-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12537184-B2 | Electrochemical device and electronic device | LBR, LAMTOR3, CACNA2D1 | CHRM1 56/4885AKR1A1 2502/4885CHRM3 110/4885 |
| US-20260094882-A1 | LITHIUM-ION BATTERY | LBR, SLC9A2, SLC8A1 | CHRM1 2251/4885AKR1A1 4732/4885CHRM3 3856/4885 |
| US-20150024284-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME | TREH, SLC6A12, SCNN1G | CHRM1 4337/4885AKR1A1 1819/4885CHRM3 4238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.